This presentation is intended to highlight the impact of caregiver burden, which includes a discussion on the challenges in recognizing agitation in Alzheimer’s dementia (AAD) and a review of helpful… Read More
This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in… Read More
This review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) with a focus on those who are living with this condition or who are caring for those who… Read More
Join us as we explore the caregivers’ insights on the “most bothersome” symptoms and what they view as meaningful improvements or worsening in agitation. We will delve into practical strategies,… Read More
This review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) with a focus on those who are living with this condition or who are caring for those who… Read More
This review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) with a focus on those who are living with this condition or who are caring for those who… Read More
Amaka Onyereri, PharmD, BCPS is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.,… Read More
This review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) with a focus on those who are living with this condition or who are caring for those who… Read More